Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization.

Thais P RochaRaiane P CrespoViviane V R YanceSylvia A HayashidaEdmund C BaracatFilomena Marília Henriques CarvalhoSorahia DomeniceBerenice B MendoncaLarissa G Gomes

Published in: Journal of the Endocrine Society (2019)

Postmenopausal hyperandrogenism is associated with adverse metabolic risk. Long-term normalization of testosterone levels did not improve BMI, glucose, or lipid metabolism.

Keyphrases

postmenopausal women
bone mineral density
polycystic ovary syndrome
replacement therapy
body mass index
body composition
blood glucose
emergency department
insulin resistance
weight gain
smoking cessation
blood pressure
breast cancer risk